Literature DB >> 25626935

Ten-years of bariatric surgery in Brazil: in-hospital mortality rates for patients assisted by universal health system or a health maintenance organization.

Silvana Márcia Bruschi Kelles1, Carla Jorge Machado1, Sandhi Maria Barreto1.   

Abstract

BACKGROUND: Bariatric surgery is an option for sustained weight loss for the morbidly obese patient. In Brazil coexists the Unified Health System (SUS) with universal coverage and from which depend 150 million Brazilians and supplemental health security, predominantly private, with 50 million beneficiaries. AIM: To compare access, in-hospital mortality, length of stay and costs for patients undergoing bariatric surgery, assisted in one or another system.
METHODS: Data from DATASUS and IBGE were used for SUS patients' and database from one health plan of southeastern Brazil for the health insurance patients.
RESULTS: Between 2001 and 2010 there were 24,342 and 4,356 surgeries performed in SUS and in the health insurance company, respectively. The coverage rates for surgeries performed in 2010 were 5.3 and 91/100.000 individuals in SUS and health insurance respectively. The rate of in-hospital mortality in SUS, considering the entire country, was 0.55 %, 0.44 % considering SUS Southeast, and 0.30 % for the health insurance. The costs of surgery in the SUS and in the health insurance trend to equalization over the years.
CONCLUSION: Despite differences in access and characteristics that may compromise the outcome of bariatric surgery, patients treated at the Southeast SUS had similar rate of in-hospital mortality compared to the health insurance patients.

Entities:  

Mesh:

Year:  2014        PMID: 25626935      PMCID: PMC4743218          DOI: 10.1590/S0102-67202014000400008

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


INTRODUCTION

Obesity has increased in Brazil in recent years, matching trends in developed countries. The Family Budget Survey 2008/2009 (Pesquisa de Orçamentos Familiares or POF 2008/2009) showed that the percentage of overweight individuals (body mass index or BMI≥25 kg/m²) aged over 20 years was 50.1% for males and 48.0% for females. For class I obese subjects (BMI≥30 kg/m²) these percentages were 12.5% for males and 16.9% for females[1]. Unpublished data have shown that the prevalence of class II obesity (BMI between 35 and 40 kg/m²) is 2.8%, of class III or morbid obesity (BMI between 40 and 50 kg/m²) is 0.7%, and of superobesity (BMI≥50 kg/m²) is 0.04% (Family Budget Survey 2008/2009 - unpublished data). In absolute numbers, it has been estimated that there will be 1.2 million morbidly obese individuals in Brazil in 2013. In the general population, the percentage of morbid obesity among women is 1%; among men it is 0.4%. A further concern is that 33.5% of children aged from 5 to 9 years, and 21.5% of youths aged from 10 to 19 years are overweight[12]. Obesity raises the mortality rate and is an independent risk factor for cardiovascular disease, arterial hypertension, and type II diabetes mellitus. The risk of early death doubles in morbidly obese patients compared to class II obese individuals[2]. Public health measures to contain the growing rates of obesity are in the agenda of government decision-makers in Brazil[22]. Meanwhile, perspectives for sustained or long term weight loss by conservative treatment among morbidly obese individuals is discouraging. Lifestyle changes and nutrition approaches fail in over 90% of cases in this group of people[28]. Another approach for sustained weight loss is bariatric surgery, which can be done using several techniques by laparotomy or laparoscopy, with varying rates of success. The Brazilian Universal Health System (Sistema Único de Saúde or SUS) has provided this procedure in the public healthcare system since 2000. The privately paid supplementary healthcare network in Brazil is required by law, since 2000, to provide bariatric surgery. The National Household Sampling Survey (Pesquisa Nacional por Amostra de Domicílios or PNAD) showed that the percentage of individuals with at least one health insurance plan was 25.9% (or 49.2 million people) in 2008. This survey also revealed that there was an association between income level and having an insurance plan. Health insurance coverage ranged from 6.4% among people with a monthly household income level below half a minimum salary to 82.5% among individuals earning more than five minimum salaries, which shows a linear relationship between purchasing power and buying health insurance[11]. Besides their social and economic profile, the ease of accessing bariatric surgery differs between users of HMOs and of the SUS (150 million Brazilians use only the latter). There is a long waiting line for bariatric surgery among SUS patients; there are few authorized centers, which are unable to meet the demand for this procedure. Waiting times for bariatric surgery through the SUS ranges from 2.2 years[21,30] to 3.4 years[15]. Such a long waiting time suggests that patients using the SUS have a different profile compared to patients with health insurance plans, for whom there is no waiting time; patients are only required to meet eligibility criteria for bariatric surgery[7]. Additionally, the health of patients who are required to wait longer may deteriorate, thereby affecting preoperative conditions and postoperative outcomes in patients operated within the SUS compared to patients who have health insurance plans. The purpose of this study was to assess whether in-hospital mortality due to bariatric surgery differs between a cohort of patients with care delivered by the SUS and a cohort of patients with care delivered by a health insurance plan, and to discuss - based on indirect data - which factors, if any, may influence these results. An assumption is that all patients in these cohorts meet the medical criteria for bariatric surgery.

METHODS

The research ethics committee of the Minas Gerais Federal University approved this study (no. COEP UFMG ETIC 0074.0.203.000-11). This study consisted of a historical nonconcurrent assessment of patients undergoing gastric bypass surgery by laparotomy for the treatment of morbid obesity, with the aim of comparing patients whose treatment was paid by the SUS and patients whose treatment was paid by a supplementary health insurance plan of an HMO in the city of Belo Horizonte. Population estimates were taken from the IBGE (Brazilian Geography and Statistics Institute) 2010 demographic census[10]. Information on SUS patients was based on data gathered from the Informatics Department of the Unified Health System (Departamento de Informática do Sistema Único de Saúde or DATASUS) and its Hospital Information System (Sistema de Informações Hospitalares or SIH) (abridged data). DATASUS operates within the Brazilian Ministry of Health; it gathers and consolidates data on hospital admittances paid for by the SUS, including the procedures that were carried out - the code of each procedure, mean hospital stays, and the costs for each region, state or city. Data was gathered for the period from January 2001 to December 2007 on the following procedures and codes: gastroplasty (33.022.04-6); vertical banded gastroplasty (33.022.12-7); Roux-en-Y gastroplasty (33.022.13-5); and gastrectomy with or without a duodenal switch (33.022.14-3). From January 2008 to December 2010, codes for the payment of bariatric surgery became: gastrectomy with or without a duodenal switch (040701012-2); Roux-en-Y gastroplasty (040701017-3); and vertical banded gastroplasty (040701018-1). The number of procedures that were carried out, the codes, the total cost, the total number of hospital stays per year, the number of in-hospital deaths, gender and age were taken from the SIH (SUS) database. Data on the BMI and comorbidities are not available in the SUS database. Data on supplementary healthcare coverage for Brazil was gathered from the DATASUS website. Data on procedures carried out by the HMO in Belo Horizonte were used to estimate the hospital stay, the cost and the mortality of patients within the same period. The administrative database of the HMO yielded information about the procedure, the hospital stay, costs, and in-hospital deaths by age and gender. This database also had data on the BMI and comorbidities at the time of surgery. Laparotomy was the access route for gastroplasty for both SUS and HMO patients during the study period. Cost values are presented historically (uncorrected for inflation) for comparison between the SUS and the HMO. Costs for the SUS and the HMO included payments to physicians, hospital fees, tariffs, hospital materials and drugs, and the cost of complications, if any. In-hospital mortality for both cohorts was considered as death occurring during the postoperative period after bariatric surgery before discharge. Data on death after hospital discharge at any time were not available. The surgical criteria were the same for both the SUS and the HMO cohorts, namely: stable obesity for at least five years; prior regular medical therapy for at least two years, which was considered ineffective; and a body mass index (BMI)≥40 kg/m2 or a BMI between 35 and 39.9 kg/m2 with life-threatening organic or psychosocial comorbidities resulting from or worsened by obesity. Other prerequisites were: age from 18 to 65 years; an understanding by the patient and by family members of the risks and consequences of surgery and post-operative therapy; and ongoing family support. Bariatric surgery was contraindicated in the following cases: obesity due to endocrine conditions; young patients in which long bone epiphyseal closure was incomplete; individuals with moderate or severe psychosis or dementia; individuals with a recent history of a attempted suicide; drug abusers (alcohol or other illegal drugs)[1]. The procedure was available for both SUS and HMO patients, generally a Roux-en-Y gastric bypass by laparotomy.

Statistics

The arithmetic mean of days in hospital, the annual mean cost, the cost per day in hospital, the mortality rate (number of deaths divided by the number of patients operated), and the mortality rate per patient/day (number of deaths divided by the total number of patients/day in hospital) were calculated for both cohorts. Data on the duration of hospitalization for patients with care delivered by the HMO were only available after 2004. The Student t test and the chi-square test were applied to study respectively the means and the proportions of SUS and HMO patients in Brazil and in Southeast Brazil. The coverage rate of the SUS for bariatric surgery was estimated based on IBGE data for the Brazilian population aged from 18 to 60 years, for each region of the country, during the study period. The denominator was the Brazilian population for each region minus the number of people covered by supplementary health insurance for each region and year to adjust the eligible population for bariatric surgery covered by the SUS and to avoid overestimating the demand. The rate of surgery among HMO-covered patients was found by dividing the number of operated patients by the number of covered patients in the same age range and study period. The mortality rate for each cohort was found by dividing the number of deaths by the number of operated patients during the study period; the relative risk (RR) was found by dividing these rates, and was used for comparison purposes. The chi-square test was applied to find the general mortality; the sample size yielded an 80% power with a 10% type alpha error. There was not enough statistical power to analyze the mortality per subgroup because there were few deaths (it was a rare event)[16]. Thus, only a descriptive analysis was made of subgroup data, with no further statistical test. A comparison of costs was made based on the total cost of the cohort per year and the cost per day. The total cost was divided by the total number of hospital stays (in days) during the time period. The SATA version 12 software was used for calculations.

RESULTS

There were 24,342 bariatric surgery procedures undertaken by the SUS in Brazil between January 2001 and December 2010; of these 10,268 were carried out in Southeast Brazil. During the same time frame, 4,356 procedures were done on patients covered by the HMO. The number of procedures on SUS patients has increased countrywide from 0.65/100.000 people (2001) to 5.23/100.000 people (2010) for patients aged from 18 to 60 years. This increase was particularly significant in South Brazil where it reached 18.8/100.000 people in 2010. Bariatric surgery among HMO patients went from 48/100.000 to 91/100.000 people in the same time period among patients aged over 18 years. The percentage of patients aged below 50 years was significantly higher among HMO patients compared to SUS patients. Table 1 shows the distribution, characteristics and deaths of SUS and HMO patients from 2001 to 2010.
Table 1

Characteristics of patients undergoing bariatric surgery by the SUS and an HMO from 2001 to 2010

VariableSUS BrazilSUS Southeast RegionHMO (supplementary healthcare)SUS Southeast x HMO P value
Number of procedures24,34210,2684,356-
Mean age (SD) in years38.2 (10.4)38.9 (10.5)36.2 (10.5)<0.001
% age≥18<50 years83.881.586.8<0.001
% age≥50<60 years15.116.310.7<0.001
% age ≥ 60 years1.12.22.40.460
Males (%)17.818.520.7<0.001
Mean hospital stay in days (SD)6.1 (0.8)6.2 (0.6)3.3 (0.2)<0.001
Number of deaths133 4513 
Mortality rate (per 1000 procedures)5.54.43.00.210
Characteristics of patients undergoing bariatric surgery by the SUS and an HMO from 2001 to 2010 Age and gender data revealed that the mean age remained stable among SUS patients but decreased by four years among HMO patients between 2001 and 2010. The percentage of male patients covered by the SUS that underwent surgery decreased four percentage points during the same time frame (Figure 1).
Figure 1

Mean hospital stay in SUS-covered patients (Brazil and Southeast Brazil) and HMO-covered patients (supplementary healthcare) from 2001 to 2010

Mean hospital stay in SUS-covered patients (Brazil and Southeast Brazil) and HMO-covered patients (supplementary healthcare) from 2001 to 2010 The BMI and comorbidities (arterial hypertension, diabetes, joint diseases, and sleep apnea) had been registered for HMO patients, but not for SUS patients. The mean BMI among HMO-covered patients decreased during the study period (Figure 2).
Figure 2

Variation of the mean BMI in patients covered by health insurance (HMO) undergoing bariatric surgery from 2002 to 2010

Variation of the mean BMI in patients covered by health insurance (HMO) undergoing bariatric surgery from 2002 to 2010 The in-hospital mortality rate was 5.5 per 1,000 operated cases among patients covered by the SUS in Brazil. It was 3.0 per 1,000 operated cases among patients covered by a HMO. The gross relative risk was 1.84 (CI 95%; 1.04-3.20). The mortality rate was 4.4 per 1,000 operated cases among SUS-covered patients in Southeast Brazil; in this case, the relative risk was 1.47 (CI 95%; 0.79-2.72) compared to the death rate of HMO-covered patients (Table 2).
Table 2

Number of procedures, deaths and mortality rates among SUS-covered patients per region in Brazil, and among HMO-covered patients

Region and site of care2001200220032004200520062007200820092010Total Mortality rate (%)
SUS North (n)536058506681105506240625 
Deaths (n)011010010150.80
SUS Northeast (n)23692081822852602533754374132,505 
Deaths (n)100011020040.20
SUS Central-West (n)0271581121311671461321761611,210 
Deaths (n)0043103012141.16
SUS Southeast (n)3656018129409441,2001,3791,2451,2841,49810,268 
Deaths (n)0637459236450.44
SUS South (n)562515425888408201.0951.3931.7722,3779,734 
Deaths (n)1137511111078640.66
SUS Brazil (n)4971,0081,7781,8722,2662,5282,9783,1953,7314,48924,342 
Deaths (n)281117121723151117133 
SUS Brazil – mortality rate (%)0.400.790.620.910.530.670.770.470.290.38 0.55
HMO (n)197875643784844124805905346304,356 
Deaths (n)000323031113 
Supplementary healthcare – mortality rate (%) 0.000.000.000.790.410.730.000.510.190.16 0.30
Number of procedures, deaths and mortality rates among SUS-covered patients per region in Brazil, and among HMO-covered patients The mortality rate among SUS-covered patients decreased during the study period from 8/1,000 procedures in 2002 to 4/1,000 in 2010. The mortality rate did not change among HMO-covered patients. The mean hospital stay fell nearly 50% among SUS-covered patients during the study period but remained stable for HMO-covered patients. The hospital stay was statistically longer among SUS-covered patients (Brazil and Southeast Brazil) compared to HMO-covered patients (p<0.0001) (Figure 3).
Figure 3

Mean hospital stay in SUS-covered patients (Brazil and Southeast Brazil) and HMO-covered patients (supplementary healthcare) from 2001 to 2010

Mean hospital stay in SUS-covered patients (Brazil and Southeast Brazil) and HMO-covered patients (supplementary healthcare) from 2001 to 2010 The in-hospital mortality rate per 1,000 patients/day-in-hospital was 0.9 (133 deaths/147.122 patients/day-in-hospital) among SUS-covered patients in Brazil and 0.7 in Southeast Brazil (45 deaths/64,083 patients-day). The mortality rate for HMO-covered patients (data is available from 2004 onwards) was 0.9/1,000 patients-day (12 deaths/13,227 patients-day). The historical value of the mean hospital stay for SUS-covered patients undergoing bariatric surgery more than doubled throughout the study period. The historical value of the mean hospital stay for HMO-covered patients remained stable during the same period. The comparison of payments in 2004 showed that the values expended by SUS corresponded of half of the ones expended by the HMO. This proportion changed through the study period, and expenditures in SUS were 80% of the value expended by the HMO in 2010. Considering that the mean hospital stay was two times in SUS, the mean cost per day for SUS ranged from one quarter to half of the cost observed in the HMO-covered patients, between 2004 and 2010 (Table 3).
Table 3

Historical value of the mean hospital stay and rate/day for bariatric surgery among SUS-covered patients (mean cost for Brazil and for Southeast Brazil) and for HMO-covered patients

  SUS Brazil SUS Southeast Brazil HMO (supplementary healthcare)
Year Mean cost of hospital stay (R$)Mean cost/day in hospital (R$)Mean cost of hospital stay (R$)Mean cost/day in hospital (R$)Mean cost of hospital stay (R$)Mean cost/day in hospital (R$)
20012,490.22336.522,441.43339.09NANA
20022,918.35374.152,857.28375.96NANA
20033,211.30428.173,128.04466.87NANA
20043,229.16474.883,135.94489.996,906.321,973.23
20053,272.35488.413,154.79463.946,989.022,184.07
20063,220.60511.213,122.61495.657,048.142,135.80
20073,448.65556.233,439.67537.457,114.232,092.42
20084,925.31864.094,819.30816.836,862.352,144.48
20095,446.521,027.655,291.81962.156,792.661,886.85
20105,467.991,093.605,321.63985.496,825.132,275.04

NA - Not available.

Historical value of the mean hospital stay and rate/day for bariatric surgery among SUS-covered patients (mean cost for Brazil and for Southeast Brazil) and for HMO-covered patients NA - Not available. Table 4 presents anthropomorphic data and comorbidities of HMO and the profile of SUS patients according to data gathered from a systematic review[14] for the study period. Differences in means and proportions were significant for all study variables, showing that the anthropomorphic profiles and comorbidities differ in the two cohorts; it is unfavorable for SUS patients from the perspective of a prognosis.
Table 4

Characteristics of patients undergoing bariatric surgery in HMO-covered and SUS-covered patients based on available data* and estimated according to asystematic review, from 2001 to 2010**

ParameterPatients covered by the SUSPatients covered by the HMODifference of means/ proportions (CI 95%)
Age in years (mean and CI 95%)38.2 (38.1 – 38.3)*36.7 (36.4 – 37.0)1.5 (1.2 – 1.9)
Males (% and CI 95%)17.8 (17.3 – 8.25)*20.7 (19.5 – 22.0)2.9 (1.6 – 4.2)
BMI in kg/m² (mean and CI 95%)49.3(47.8 – 50.8)**43.3 (43.2 – 43.5)6.0 (5.7 – 6.4)
Arterial hypertension (% and CI 95%)47.4 (44.8 – 0.1)**39.6 (38.2 – 41.1)7.8 (4.8 – 10.8)
Diabetes (% and CI 95%)17.3 (15.4 – 9.4)**12.1 (11.2 – 13.2)5.2 (3.0 – 7.5)
Arthropathy (% and CI 95%)21.1 (18.8– 23.6)**13.8 (12.9 – 14.9)7.3 (4.7 – 10.0)
Sleep apnea (% and CI 95%)14.6 (12.6 –16.8)**6.4 (5.7 – 7.2)8.2 (6.1 – 10.6)

Source of data:SIH SUS

Reference[14]

Characteristics of patients undergoing bariatric surgery in HMO-covered and SUS-covered patients based on available data* and estimated according to asystematic review, from 2001 to 2010** Source of data:SIH SUS Reference[14]

DISCUSSION

A low in-hospital death rate after bariatric surgery among patients covered by the SUS and an HMO shows that this is a low-risk procedure in the short term. The in-hospital mortality rate among SUS-covered patients in Brazil was 84% higher than that of patients covered by supplementary healthcare (HMO); the rate, however, was similar between SUS-covered patients in Southeast Brazil and HMO-covered patients. Mortality adjusted for the duration of hospital stay was similar between SUS and HMO patients, because the mean hospital stay of SUS-covered patients was about twice that of HMO-covered patients. A time trend analysis shows a consistent fall in the mortality rate for both SUS and HMO patients; this was more evident among SUS-covered patients, bringing both rates closer across the study period. Such a decrease may reflect the growing experience of surgeons and hospital teams with the postoperative care of bariatric surgery patients.[13,26] Brazilian and international data on in-hospital mortality after bariatric surgery has ranged from 0.5 to 3.6% in non-laparoscopic procedures within the past 10 years; most papers have published a value closer to 0.5%. Massomi et al [17] found an in-hospital mortality rate of 0.52% among 42,591 patients in the United States undergoing non-laparoscopic bariatric surgery between 2006 and 2008. Padwal (2005) reported a 0.5% death rate among 1,100 patients operated in 2002 and 2003 in Canada.[24] The mortality rate for 2005 was 0.32% among 4,040 patients (laparotomy gastric bypass) in Chile.[5] Santo et al, in Brazil, reported a 0.55% mortality rate in a retrospective survey of 538 patients operated between 2006 and 2011 at the Clinic Hospital, São Paulo University.[24] Diniz et al found a higher rate (3.6%) in a cohort operated in the city of Belo Horizonte from 1998 to 2005.[6] Thus, in-hospital mortality rates of SUS-covered patients in Brazil (0.55%) and in Southeast Brazil (0.44%), and HMO-covered patients (0.33%) are similar to the best published results, which suggests that a longer access time for surgery (in the case of SUS patients) does not alter the risk of in-hospital death. Possibly HMO-covered patients stay less in hospital because their access to preoperative tests and assessments is easier compared to SUS-covered patients. Salgado Jr[23] reported that SUS patients at his unit were admitted to hospital six days before surgery for lab tests and a multiprofessional evaluation. A consistent fall in the hospital stay of SUS-covered patients has been noted - from 7.4 days in 2001 to 5 days in 2010. Age and gender are the only verified factors that may directly affect in-hospital morbidity/mortality in the study cohorts. The percentage of male patients covered by the SUS undergoing bariatric surgery decreased during the study period. A few authors have suggested that being male is a risk factor for postoperative death following bariatric surgery[29]; such a decrease among men may reduce the mortality rate. The mean age of operated SUS patients was nearly three years higher compared to HMO-covered patients, which may alter the risk of surgery positively for the HMO. The frequency of HMO patients aged below 50 years was significantly lower compared to SUS patients. There was no statistically significant difference between the cohorts among patients aged 60 years or over. The mean age of SUS patients remained stable, whereas it decreased among HMO patients. Such a decrease has not been reported in the literature; on the contrary, published results have shown an increase in the mean age of operated patients.[25] Unfortunately the BMI and comorbidities of SUS-covered patients was not reported. A systematic review[14] suggests that these patients have a higher BMI and more comorbidities - arterial hypertension, diabetes and sleep apnea - all of which are associated with a higher operative and postoperative mortality. The mean BMI at surgery has decreased each year in HMO-covered patients. A lower mean BMI and age certainly have a positive effect on the operatory mortality rate. The SUS is the main paying agent of hospital admittances in Brazil. Information on hospital admittances comprises the Hospital Information System of the SUS (SIH/SUS). Data is gathered from Hospital Admittance Authorization forms (AIH), processed and made available nationally. The AIH includes several variables, namely: identification, description of the hospital, cash paid for hospital admittance, the nature of the medical event, the hospital stay, and the patient's outcome or reason for leaving the hospital. Hospitals use this form to write the invoice, which is generated according to a table published by the SUS to calculate the amount paid for procedures[4]. In the present study, the cost of bariatric surgery consisted only of historical values of hospital stays, since the aim was to compare the cost of hospital admittances year by year between both cohorts. The cost per day of an HMO-covered patient was four times higher than that of SUS-covered patients in 2004; this difference, however, decreased across the study period. It is worth noting that the duration of hospital stays of SUS patients fell during the study period. Thus, the mean cost per day of hospitalization of SUS patients is less than half that of HMO patients if we consider that the hospital stay was nearly double for SUS patients. A further point to consider is that SUS accounts may be invoiced at lower values, thereby underreporting the costs. In this study were only able to estimate the true coverage of the SUS by calculating it for 100,000 inhabitants/year. There are two healthcare systems in Brazil, as follows: universal coverage by the SUS, and supplementary healthcare (HMO) for individuals that are able to pay for health insurance or are fully employed by companies that provide health insurance plans. The coverage rate of supplementary health has increased in Brazil between 2001 and 2010 for individuals aged 20 years or above (from 20.8% to 24.8%). Because HMO-covered patients can access bariatric surgery more easily, estimates of the population eligible for SUS coverage only exclude the number of individuals with health insurance from the general population that may seek SUS healthcare (denominator). Thus, while the total rate of coverage of bariatric surgery by the SUS may be underestimated because the denominator is likely to be less accurate, the rate of surgery undertaken by the HMO may be overestimated because of "moral hazard" pressures. Several individuals hire health insurance after they have acquired morbid obesity in order to be operated. In the present study, about 20% of patients undergoing bariatric surgery had hired the health insurance plan one year before surgery. Thus, any comparison between rates of surgery in both systems is inadequate because each system has its own peculiarities. The rate of the SUS can be used to compare its ability to provide care with that of other universal systems. The National Institute for Health and Care Excellence (NICE)[18] has estimated that 10 bariatric surgeries per 100,000 inhabitants were needed in 2012, which is twice the current number among SUS-covered patients in Brazil; the population of morbidly obese patients in that year - one million individuals - was similar to that in Brazil[9]. The rate of bariatric surgeries in the United States was 63.9/100,000 adults in 2004, falling to 54.2/100,000 in 2008[19]. The estimated number of morbidly obese patients in the US in 2012 was 15.5 million persons[27]. The waiting time for bariatric surgery for SUS patients ranges from one to four years[6,15,21,30]. The mean waiting time for this procedure in Canada (2011), which has universal healthcare and 0.8 million morbidly obese patients[8], was 5.2 years[3]. It appears, therefore, that these patients covered by universal healthcare in Canada face similar difficulties to those in Brazil. Meanwhile, HMO-covered patients enjoy near immediate access if they meet eligibility criteria. This study has other limitations besides an imprecise estimate of coverage. The most important is having only aggregate data from the SUS. Calculating the number of procedures that were actually done is another limitation of this study. Although the number of operations is available and accurate, the denominator - the population that counts only on the SUS - was only estimated, and the number of patients with supplementary healthcare was deduced from this number. Numbers may be less than accurate because there are several modes of supplementary healthcare, not all of which provide hospital admittance. Even so, rates may be presented to estimate the order of magnitude of the differences. Another limitation of this study is that relevant data, such as comorbidities among SUS patients, are not available. Finally, data on patients covered by the HMO may not reflect the reality of supplementary healthcare as a whole in Brazil.

CONCLUSIONS

In-hospital mortality after bariatric surgery is a rare event. The numbers for both cohorts concur with other published results from developed countries and for laparotomy as the access route. The rate of in-hospital mortality was similar in HMO-covered patients and in patients covered by the SUS in Southeast Brazil, even though the latter face more difficulties in accessing this procedure and are a few years older. If the rate of surgery for SUS-covered patients appears to fall below the demand, compared to internationally published results, the rate in supplementary healthcare is higher compared to that in several developed countries. Moral hazard may certainly explain part of this difference; other reasons require further study, such as over-prescription of surgery in supplementary healthcare. The long term consequences of a lower age and lower BMI at the time of surgery are not known.
  17 in total

1.  Costs of bariatric surgery in a teaching hospital and the financing provided by the Public Unified Health System.

Authors:  Wilson Salgado Júnior; Karoline Calfa Pitanga; José Sebastião dos Santos; Ajith Kumar Sankarankutty; Orlando de Castro e Silva; Reginaldo Ceneviva
Journal:  Acta Cir Bras       Date:  2010-04       Impact factor: 1.388

2.  Factors influencing survival following surgical treatment of obesity.

Authors:  Wei Zhang; Edward E Mason; Kathleen E Renquist; M Bridget Zimmerman
Journal:  Obes Surg       Date:  2005-01       Impact factor: 4.129

3.  Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement.

Authors: 
Journal:  Am J Clin Nutr       Date:  1992-02       Impact factor: 7.045

4.  [Information from the invoicing sector as support for decision-making: a case study at the University Hospital of the Federal University of Grande Dourados (UFGD)].

Authors:  Renato Fabiano Cintra; Saulo Fabiano Amâncio Vieira; Rosemar José Hall; Cristiano Rodrigues Fernandes
Journal:  Cien Saude Colet       Date:  2013-10

5.  Early complications in bariatric surgery: incidence, diagnosis and treatment.

Authors:  Marco Aurelio Santo; Denis Pajecki; Daniel Riccioppo; Roberto Cleva; Flavio Kawamoto; Ivan Cecconello
Journal:  Arq Gastroenterol       Date:  2013 Jan-Mar

6.  Trends in use of bariatric surgery, 2003-2008.

Authors:  Ninh T Nguyen; Hossein Masoomi; Cheryl P Magno; Xuan-Mai T Nguyen; Kelly Laugenour; John Lane
Journal:  J Am Coll Surg       Date:  2011-05-31       Impact factor: 6.113

7.  Body-mass index and mortality in a prospective cohort of U.S. adults.

Authors:  E E Calle; M J Thun; J M Petrelli; C Rodriguez; C W Heath
Journal:  N Engl J Med       Date:  1999-10-07       Impact factor: 91.245

8.  Relationship between surgeon volume and adverse outcomes after RYGB in Longitudinal Assessment of Bariatric Surgery (LABS) study.

Authors:  Mark D Smith; Emma Patterson; Abdus S Wahed; Steven H Belle; Marc Bessler; Anita P Courcoulas; David Flum; Valerie Halpin; James E Mitchell; Alfons Pomp; Walter J Pories; Bruce Wolfe
Journal:  Surg Obes Relat Dis       Date:  2009-09-26       Impact factor: 4.734

9.  Overview of outcomes of laparoscopic and open Roux-en-Y gastric bypass in the United States.

Authors:  Hossein Masoomi; Ninh T Nguyen; Michael J Stamos; Brian R Smith
Journal:  Surg Technol Int       Date:  2012-12

10.  Morbid obesity rates continue to rise rapidly in the United States.

Authors:  R Sturm; A Hattori
Journal:  Int J Obes (Lond)       Date:  2013-06       Impact factor: 5.095

View more
  8 in total

1.  Bariatric Surgery Offer in Brazil: a Macroeconomic Analysis of the Health system's Inequalities.

Authors:  Everton Cazzo; Almino Cardoso Ramos; Elinton Adami Chaim
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

2.  Nationwide Macroeconomic Variables and the Growth Rate of Bariatric Surgeries in Brazil.

Authors:  Everton Cazzo; Almino Cardoso Ramos; José Carlos Pareja; Elinton Adami Chaim
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

3.  Cost-Utility of Gastric Bypass Surgery Compared to Clinical Treatment for Severely Obese With and Without Diabetes in the Perspective of the Brazilian Public Health System.

Authors:  Roberto Pereira Assumpção; Luciana Ribeiro Bahia; Michelle Quarti Machado da Rosa; Marcelo Goulart Correia; Everton Nunes da Silva; Paula Rosales Zubiaurre; Claudio Corá Mottin; Denizar Araujo Vianna
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

4.  Immediate postoperative of bariatric surgery in the intensive care unit versus an inpatient unit. A retrospective study with 828 patients.

Authors:  Guilherme Loures de Araújo Penna; Igor Pedreira Vaz; Eduardo Côrtes Fonseca; Marcelo Kalichsztein; Gustavo Freitas Nobre
Journal:  Rev Bras Ter Intensiva       Date:  2017 Jul-Sep

Review 5.  WHEN AND WHY OPERATE ELDERLY OBESE.

Authors:  Paulo Afonso Nunes Nassif; Osvaldo Malafaia; Jurandir Marcondes Ribas-Filho; Nicolau Gregori Czeczko; Rodrigo Ferreira Garcia; Bruno Luiz Ariede
Journal:  Arq Bras Cir Dig       Date:  2015

6.  Real-world evidence of health outcomes and medication use 24 months after bariatric surgery in the public healthcare system in Brazil: a retrospective, single-center study.

Authors:  Denis Pajecki; Flavio Kawamoto; Anna Carolina Batista Dantas; Priscila Caldeira Andrade; Nissia Capello Brasil; Silvio Mauro Junqueira; Fernanda Maria Pirozelli de Oliveira; Rodrigo Antonini Ribeiro; Marco Aurelio Santo
Journal:  Clinics (Sao Paulo)       Date:  2020-04-06       Impact factor: 2.365

7.  A Retrospective Study about the Differences in Cardiometabolic Risk Indicators and Level of Physical Activity in Bariatric Surgery Patients from Private vs. Public Units.

Authors:  Rebeca Rocha de Almeida; Márcia Ferreira Cândido de Souza; Dihogo Gama de Matos; Larissa Monteiro Costa Pereira; Victor Batista Oliveira; Joselina Luzia Menezes Oliveira; José Augusto Soares Barreto-Filho; Marcos Antonio Almeida-Santos; Raphael Fabrício de Souza; Aristela de Freitas Zanona; Victor Machado Reis; Felipe J Aidar; Antônio Carlos Sobral Sousa
Journal:  Int J Environ Res Public Health       Date:  2019-11-27       Impact factor: 3.390

8.  Changes in the intestinal microbiota of superobese patients after bariatric surgery.

Authors:  Denis Pajecki; Lea Campos de Oliveira; Ester Cerdeira Sabino; Marcela de Souza-Basqueira; Anna Carolina Batista Dantas; Gabriel Cairo Nunes; Roberto de Cleva; Marco Aurélio Santo
Journal:  Clinics (Sao Paulo)       Date:  2019-10-28       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.